Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
    -0.15p
  • 52 Week High: 4.80
  • 52 Week Low: 2.10
  • Currency: UK Pounds
  • Shares Issued: 803.36m
  • Volume: 159,984
  • Market Cap: £26.51m

Eden Research Overview

Eden Research is in the pharma and biotech sector and is currently trading at 3.30p per share. In the last year Eden Research's share price has ranged from 2.10p to 4.80p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -50.8% -56.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 5.2 4.5
Pr/Book 1.9  
Latest F'cast
Revenue 34.8% 16.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Eden Research Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.37 (2.55) (0.66)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.23 (3.40) (0.73)p n/a n/a n/a n/a 0.0%
31-Dec-22 1.83 (2.57) (0.59)p n/a n/a n/a n/a 0.0%
31-Dec-23 3.19 (6.92) (1.54)p n/a n/a n/a n/a 0.0%
31-Dec-24 4.30 (2.18) (0.36)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Eden Research Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 5.00 (2.80) (0.47)p n/a n/a n/a n/a 0.0%
31-Dec-26 6.10 (3.00) (0.35)p n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Eden Research Company Announcements

Directorate change 27-May-2026 07:00 RNS
Trading Update 28-Apr-2026 07:00 RNS
Holding(s) in Company 16-Apr-2026 14:59 RNS

Eden Research ShareCast News

Eden Research gets biopesticide label extension ... 07-Jan-2026 ShareCast
Eden Research's Ecovelex gets another temporary ... 17-Nov-2025 ShareCast
Eden Research enters strategic partnership with ... 16-Jun-2025 ShareCast

Latest Eden Research Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.30p
Change Today -0.15p
% Change -4.35 %
52 Week High 4.80
52 Week Low 2.10
Volume 159,984
Shares Issued 803.36m
Market Cap £26.51m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.18% below the market average10.18% below the market average10.18% below the market average10.18% below the market average10.18% below the market average
17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average
Price Trend
56.69% below the market average56.69% below the market average56.69% below the market average56.69% below the market average56.69% below the market average
22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average
Income Not Available
Growth
55.15% above the market average55.15% above the market average55.15% above the market average55.15% above the market average55.15% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average

Eden Research Dividends

No dividends found

Trades for 03-Jun-2026

Time Volume / Share Price
15:12 20,000 @ 3.39p
14:59 20,000 @ 3.39p
14:25 19,000 @ 3.22p
14:00 19,852 @ 3.40p
13:46 6,737 @ 3.20p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page